Novel insights into the aetiology of granulomatosis with polyangiitis—a case–control study using the Clinical Practice Research Datalink
暂无分享,去创建一个
R. Hubbard | M. Grainge | P. Lanyon | R. Watts | A. Abhishek | F. Pearce
[1] Cisca Wijmenga,et al. The MHC locus and genetic susceptibility to autoimmune and infectious diseases , 2017, Genome Biology.
[2] Richard A Watts,et al. The incidence, prevalence and mortality of granulomatosis with polyangiitis in the UK Clinical Practice Research Datalink , 2016, Rheumatology.
[3] C. Tcherakian,et al. Antineutrophil cytoplasmic antibodies (ANCA) associated-bronchiectasis appears more severe than “idiopathic” bronchiectasis , 2015 .
[4] J. Pers,et al. ANCA-associated vasculitis in patients with primary Sjögren's syndrome: detailed analysis of 7 new cases and systematic literature review. , 2015, Autoimmunity reviews.
[5] K. Bhaskaran,et al. Data Resource Profile: Clinical Practice Research Datalink (CPRD) , 2015, International journal of epidemiology.
[6] C. Théodore,et al. Successful treatment of antineutrophil cytoplasmic antibody-associated bronchiectasis with immunosuppressive therapy , 2015, European Respiratory Journal.
[7] David Moher,et al. The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines , 2015, PloS one.
[8] A. Mocroft,et al. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study , 2015, PLoS medicine.
[9] A. Salama,et al. Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome , 2015, SpringerPlus.
[10] C. Cappi,et al. An Inherited Small Microdeletion at 15q13.3 in a Patient with Early- Onset Obsessive-Compulsive Disorder , 2014, PloS one.
[11] T. Neri,et al. Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art , 2014, Front. Immunol..
[12] D. Reeves,et al. ClinicalCodes: An Online Clinical Codes Repository to Improve the Validity and Reproducibility of Research Using Electronic Medical Records , 2014, PloS one.
[13] J. Mooney. What are the informational needs of patients with ANCA-associated vasculitis? : a mixed methods study , 2014 .
[14] S. Sacre,et al. Emerging Role of Endosomal Toll-Like Receptors in Rheumatoid Arthritis , 2013, Front. Immunol..
[15] C. Denton,et al. Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors. , 2013, Rheumatology.
[16] A. Condliffe,et al. Coexistence of Bronchiectasis and Rheumatoid Arthritis: Revisited , 2013, Respiratory Care.
[17] J. Anaya,et al. How do autoimmune diseases cluster in families? A systematic review and meta-analysis , 2013, BMC Medicine.
[18] K. Siminovitch,et al. Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis. , 2012, Arthritis and rheumatism.
[19] Garth L Burn,et al. Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? , 2011, FEBS letters.
[20] P. Merkel,et al. A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis , 2011, Arthritis care & research.
[21] P. Merkel,et al. Alpha 1 -Antitrypsin Deficiency–Related Alleles Z and S and the Risk of Wegener’s Granulomatosis , 2011 .
[22] R. Wilson,et al. Bronchiectasis and autoimmune disease , 2011 .
[23] L. Smeeth,et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review , 2010, British journal of clinical pharmacology.
[24] Glinda S Cooper,et al. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. , 2009, Journal of autoimmunity.
[25] D. Scott,et al. Prevalence and incidence of Wegener's granulomatosis in the UK general practice research database. , 2009, Arthritis and rheumatism.
[26] G. Bishop,et al. CD40 and autoimmunity: the dark side of a great activator. , 2009, Seminars in immunology.
[27] Irene Petersen,et al. Creating medical and drug code lists to identify cases in primary care databases , 2009, Pharmacoepidemiology and drug safety.
[28] K. Scalapino,et al. CTLA‐4: a key regulatory point in the control of autoimmune disease , 2008, Immunological reviews.
[29] Emile de Heer,et al. Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[30] R. Falk,et al. Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[31] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[32] L. Stamp,et al. Wegener’s granulomatosis in New Zealand: evidence for a latitude‐dependent incidence gradient , 2007, Internal medicine journal.
[33] S. Galandiuk,et al. Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.
[34] L. Smeeth,et al. Autoimmune Diseases Co-occurring Within Individuals and Within Families: A Systematic Review , 2006, Epidemiology.
[35] Northgate. Hospital Episode Statistics , 2006 .
[36] M. Benucci,et al. [Bronchiectasis worsening by p-ANCA (bactericidal/permeability-increasing protein) positive vasculitis. A case report and review of the literature]. , 2005, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna.
[37] M. Haubitz,et al. Smoking habits in patients diagnosed with ANCA associated small vessel vasculitis , 2005, Annals of the rheumatic diseases.
[38] W. Bilker,et al. The relationship between time since registration and measured incidence rates in the General Practice Research Database , 2005, Pharmacoepidemiology and drug safety.
[39] K. Takahashi,et al. Development of Microscopic Polyangiitis in Patients with Chronic Airway Disease , 2005, Lung.
[40] L. Maier. Is smoking beneficial for granulomatous lung diseases? , 2004, American journal of respiratory and critical care medicine.
[41] D. Roos,et al. Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies. , 2004, Human immunology.
[42] M. Sopori,et al. Effects of cigarette smoke on the immune system , 2002, Nature Reviews Immunology.
[43] S. Pearce,et al. An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. , 2002, Rheumatology.
[44] C. Kallenberg,et al. Staphylococcus aureus and Wegener's granulomatosis , 2001, Arthritis research.
[45] M. Osame,et al. Bronchiectasis with myeloperoxidase antineutrophil cytoplasmic antibody and bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibody. , 1999, Internal medicine.
[46] N. Cary,et al. Vasculitis and bronchiectasis in a patient with antibodies to bactericidal/permeability-increasing protein and alpha1-antitrypsin deficiency. , 1997, Chest.
[47] J. Hollowell,et al. The General Practice Research Database: quality of morbidity data. , 1997, Population trends.
[48] N. Booth. What are the Read Codes? , 1994, Health libraries review.